Atreca, Inc. 4 SEC Filings

Filed On	Filing
17 Apr 2024	Form 4: Orwin John A, Director Bought 1 shares ($0.01)
03 Apr 2024	Form 4: Serafini Tito, Director Sold 20,788 shares ($1.46K)
03 Apr 2024	Form 4: Orwin John A, Director Sold 22,951 shares ($8.6K)
03 Apr 2024	Form 4: Serafini Tito, Director Sold 8,393 shares ($3.14K)
03 Apr 2024	Form 4: Courtney Phillips, GENERAL COUNSEL & SECRETARY Sold 7,061 shares ($2.65K)
23 Oct 2023	Form 4: Baker Bros. Advisors Lp, Former 10% Owner and 3 others Sold 274,739 shares ($111K)
04 Aug 2023	Form 4: Serafini Tito, Director Sold 5,487 shares ($5.22K)
04 Aug 2023	Form 4: Cross Herb, Chief Financial Officer Sold 5,487 shares ($5.22K)
04 Aug 2023	Form 4: Gould Stephen E, Chief Scientific Officer Sold 4,076 shares ($3.88K)
04 Aug 2023	Form 4: Courtney Phillips, General Counsel & Secretary Sold 4,076 shares ($3.88K)
15 Jun 2023	Form 4: Rolfe Lindsey, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Robinson William Hewitt, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Ma Stacey, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Lacey David L., Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Brady Stephen R, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Berger Franklin M, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Ball Kristine M, Director Granted 12,000 Stock Option (right to buy)
15 Jun 2023	Form 4: Atwood Brian G, Director Granted 12,000 Stock Option (right to buy)
13 Feb 2023	Form 4: Gould Stephen E, Chief Scientific Officer Received 32,500 shares as a grant or award · Granted 130,000 Employee stock option (right to buy)
13 Feb 2023	Form 4: Orwin John A, Director Granted 435,000 Employee stock option (right to buy)

Comments